XML 24 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Debt And Derivative Instruments
3 Months Ended
Mar. 31, 2021
Debt And Derivative Instruments [Abstract]  
Debt And Derivative Instruments (6) Debt and Derivative Instruments

Debt

Details of the Company’s debt as of March 31, 2021 and December 31, 2020 were as follows (dollars in thousands):

March 31, 2021

December 31, 2020

Outstanding

Average

Outstanding

Average

Current

Long-term

Interest

Current

Long-term

Interest

Maturity

Revolving credit (1)

$

-

$

793,000 

1.4%

$

-

$

680,000 

1.6%

June 2023

Revolving credit facility - Euro

-

22,519 

2.4%

-

23,550 

2.5%

September 2023

Term loan

1,800 

23,250 

2.2%

1,800 

23,700 

2.2%

April 2023

Term loan

66,750 

-

1.9%

68,500 

-

1.9%

June 2021

Term loan

6,000 

79,000 

4.6%

6,000 

80,500 

4.6%

October 2023

Senior secured notes

6,110 

37,500 

4.9%

6,110 

40,555 

4.9%

September 2022

Asset-backed notes 2020-1

63,130 

648,006 

2.3%

63,130 

663,788 

2.3%

September 2045

Collateralized financing obligations

37,852 

23,776 

1.8%

35,862 

33,767 

1.7%

February 2026

Term loans held by VIE

5,540 

24,344 

4.2%

5,482 

25,752 

4.2%

February 2026

187,182 

1,651,395 

186,884 

1,571,612 

Debt discount and debt issuance costs

(3,304)

(8,516)

(3,436)

(9,329)

Total Debt

$

183,878 

$

1,642,879 

$

183,448 

$

1,562,283 

(1) $500 million of this outstanding debt is subject to an interest rate swap at a cost of 0.29% as described below in Derivative Instruments.

The Company maintains its revolving credit facilities to finance the acquisition of rental equipment and for general working capital purposes. As of March 31, 2021, the Company had $388.7 million in total availability under its revolving credit facilities (net of $0.1 million in letters of credit), subject to the Company’s ability to meet the collateral requirements under the agreements governing the facilities. Based on the borrowing base and collateral requirements at March 31, 2021, the borrowing availability under the Company’s revolving credit facilities was $248.8 million, assuming no additional contributions of assets.

The agreements relating to all of the Company’s debt contain various financial and other covenants. As of March 31, 2021, the Company was in compliance with all of its financial and other covenants.

For further information on the Company’s debt instruments, see Note 7 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 1, 2021.

Derivative Instruments

In July 2020, the Company entered into an interest rate swap agreement with an effective date of July 31, 2020 and scheduled maturity date of June 30, 2025. This contract is indexed to 1-month LIBOR, has a fixed leg interest rate of 0.29%, and a notional amount of $500.0 million.

As of March 31, 2021, the Company has designated interest rate swap agreements for a total notional amount of $500.0 million as cash flow hedges for accounting purposes. The change in fair value of cash flow hedging instruments during the three months ended March 31, 2021 was recorded on the consolidated balance sheets in ‘Accumulated other comprehensive loss’ and reclassified to ‘Net interest expense’ when realized. The Company had no derivative instruments as of March 31, 2020.

Over the next twelve months, the Company expects to reclassify an estimated net loss of $0.6 million related to the designated interest rate swap agreements from ‘Accumulated other comprehensive loss’ in the consolidated statements of comprehensive income to ‘Net interest expense’ in the consolidated statements of operations.

The following table summarizes the impact of derivative instruments designated in cash flow hedging relationships on the consolidated statements of operations and the consolidated statements of comprehensive income (loss) on a pretax basis (in thousands):

Three Months Ended March 31,

Derivative Instrument

Financial Statement Caption

2021

2020

Interest rate swap

Comprehensive income

$

9,509

$

-

Interest rate swap

Net interest expense

$

157

$

-

The fair value of derivative instruments on the Company’s consolidated balance sheets of March 31, 2021 and December 31, 2020 was as follows (in thousands):

Total

Fair Value

Level 2

March 31, 2021

Derivative assets - interest rate swaps

$

9,586

$

9,586

December 31, 2020

Derivative liabilities - interest rate swaps

$

80

$

80